BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2905287)

  • 1. Intracervical administration of prostaglandin E2-gel prior to therapeutic abortion: a prospective randomized double-blind study.
    Shalev E; Tsabari A; Edelstein S; Weiner E; Zuckerman H
    Int J Gynaecol Obstet; 1988 Aug; 27(1):119-22. PubMed ID: 2905287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double blind study of a new ready-for use prostaglandin gel (Org 2436) for cervical ripening prior to first trimester pregnancy termination.
    Osmers R; Rath W; Conrad A; Kuhn W
    Zentralbl Gynakol; 1990; 112(9):545-54. PubMed ID: 2378185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilatation of the cervix by oral PGE2 before first-trimester termination of pregnancy.
    Somell C; Olund A; Kindahl H; Larsson B
    Acta Obstet Gynecol Scand; 1984; 63(7):625-8. PubMed ID: 6393687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative cervical preparation before first trimester missed abortion: a randomized controlled comparison between single or double intracervical administration of PGE2 gel.
    Ragusa A; Vignali M; Zanetta G; Norchi S; Zanini A
    Prostaglandins Leukot Essent Fatty Acids; 1994 May; 50(5):267-9. PubMed ID: 8066102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of prostaglandin E2 pessaries and laminaria tents for ripening the cervix before termination of pregnancy.
    Killick SR; Vaughan Williams CA; Elstein M
    Br J Obstet Gynaecol; 1985 May; 92(5):518-21. PubMed ID: 3857938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracervical PGE2-gel on myometrial activity and cervical state in first trimester pregnancy.
    Forman A; Ulmsten U; Wingerup L; Bányai J
    Prostaglandins; 1982 Sep; 24(3):303-12. PubMed ID: 6961477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
    Cohn M; Stewart P
    Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracervical administration of prostaglandin E2 prior to vacuum aspiration. A prospective double-blind randomized study.
    Iversen T; Skjeldestad FE
    Int J Gynaecol Obstet; 1985 Apr; 23(2):95-9. PubMed ID: 2862081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 gel for cervical ripening and induction of labor: a critical analysis.
    Rayburn WF
    Am J Obstet Gynecol; 1989 Mar; 160(3):529-34. PubMed ID: 2648830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ripening of the uterine cervix and induction of labour at term with prostaglandin E2 in viscous gel.
    Wingerup L; Andersson KE; Ulmsten U
    Acta Obstet Gynecol Scand; 1978; 57(5):403-6. PubMed ID: 364917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a local effect of intracervical prostaglandin E2-gel.
    Forman A; Ulmsten U; Bányai J; Wingerup L; Uldbjerg N
    Am J Obstet Gynecol; 1982 Aug; 143(7):756-60. PubMed ID: 6954849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ripening of the cervix by intracervical application of PGE2-gel before termination of pregnancy with dilatation and evacuation.
    Wingerup L; Ulmsten U; Andersson KE
    Acta Obstet Gynecol Scand Suppl; 1979; 84():15-8. PubMed ID: 377896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midtrimester induction of abortion: comparison of extraovular prostaglandin E2 and intra-amniotic prostaglandin F2 alpha.
    Lurie S; Katz Z; Insler V
    Contraception; 1993 May; 47(5):475-81. PubMed ID: 8513674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
    Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences with a new gel for intracervical application of prostaglandin E2 before therapeutic abortion or induction of term labor.
    Ulmsten U; Wingerup L
    Prostaglandins; 1980 Sep; 20(3):533-46. PubMed ID: 6999546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.